Drug · DIN 02242880
PREMPLUS CYCLE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since November 6, 2019.
- Drug Identification Number (DIN)
- 02242880
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Kit; Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Medroxyprogesterone and estrogen G03FA12
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CONJUGATED ESTROGENS | 0.625 MG | |
| MEDROXYPROGESTERONE ACETATE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 1, 2010: NOC 11782New Drug Submission (NDS) · Manufacturer name change
- April 3, 2003: NOC 408New Drug Submission (NDS) · Manufacturer name change
- October 16, 2000: NOC 1032New Drug Submission (NDS)